Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $84,088 - $169,095
-18,360 Reduced 41.2%
26,200 $181,000
Q2 2022

Aug 08, 2022

SELL
$7.06 - $23.63 $385,490 - $1.29 Million
-54,602 Reduced 55.06%
44,560 $373,000
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $64,800 - $83,370
3,000 Added 3.12%
99,162 $2.27 Million
Q4 2021

Feb 09, 2022

BUY
$23.0 - $29.01 $145,682 - $183,749
6,334 Added 7.05%
96,162 $2.66 Million
Q3 2021

Nov 12, 2021

BUY
$25.04 - $30.06 $180,288 - $216,432
7,200 Added 8.71%
89,828 $2.5 Million
Q2 2021

Aug 11, 2021

BUY
$27.43 - $32.7 $869,421 - $1.04 Million
31,696 Added 62.23%
82,628 $2.42 Million
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $552,072 - $888,172
-25,834 Reduced 33.65%
50,932 $1.62 Million
Q4 2020

Feb 11, 2021

SELL
$15.31 - $21.12 $23,485 - $32,398
-1,534 Reduced 1.96%
76,766 $1.6 Million
Q3 2020

Nov 12, 2020

SELL
$14.88 - $20.13 $156,240 - $211,365
-10,500 Reduced 11.82%
78,300 $1.22 Million
Q2 2020

Oct 22, 2020

SELL
$13.31 - $20.51 $131,769 - $203,049
-9,900 Reduced 10.03%
88,800 $1.62 Million
Q2 2020

Aug 14, 2020

SELL
$13.31 - $20.51 $93,170 - $143,570
-7,000 Reduced 6.62%
98,700 $2.95 Million
Q1 2020

May 14, 2020

BUY
$12.98 - $30.25 $12,980 - $30,250
1,000 Added 0.96%
105,700 $1.64 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $143,564 - $242,364
7,600 Added 7.83%
104,700 $3.13 Million
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $411,336 - $505,502
19,700 Added 25.45%
97,100 $2.12 Million
Q2 2019

Aug 14, 2019

BUY
$20.52 - $26.45 $1.59 Million - $2.05 Million
77,400 New
77,400 $1.95 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.